Myxomatous degeneration of the mitral valve is the

Size: px
Start display at page:

Download "Myxomatous degeneration of the mitral valve is the"

Transcription

1 CARDIOVASCULAR Midterm Results of the Edge-to-Edge Technique for Complex Mitral Valve Repair Derek R. Brinster, MD, Daniel Unic, MD, Michael N. D Ambra, MD, Nadia Nathan, MD, and Lawrence H. Cohn, MD Division of Cardiac Surgery and Cardiac Anesthesia, Brigham and Women s Hospital, and the Department of Surgery and Anesthesia, Harvard Medical School, Boston, Massachusetts Background. The edge-to-edge technique (E2E) has been advocated for the complex repair of myxomatous mitral valves. We compared outcomes of E2E performed in patients at risk for systolic anterior motion (SAM) versus outcomes in patients with residual mitral regurgitation (MR) after repair completion. Methods. A total of 1,612 patients had repair of myxomatous mitral valves between June 1997 and December 2003 at Brigham and Women s Hospital. The E2E was used in 72 (4.5%) patients. Fifty-two patients (52/72; group I) had E2E for persistent MR after complex repair. Twenty patients (20/72; group II) had E2E for high risk of post-repair SAM and left ventricular outflow tract obstruction. Mean age of the patients was years; 47 were male, average New York Heart Association class at admission was , and mean left ventricular ejection fraction was 56 12%. Results. The operative mortality was zero. Immediate postoperative MR was significantly improved in all patients compared with the preoperative grade (p value < ). Mean follow-up was 388 days. In those in whom E2E was used for residual MR without SAM risk (group I), postoperative MR (> 2 ) was detected in 15 of 52 patients at 6 months. In group II, SAM was completely eliminated and the mean MR grade in the immediate postoperative period was There was no longterm recurrence of MR in group II. Conclusions. This study suggests that E2E eliminates SAM and long-term MR in patients with pre-repair echocardiographic predictors of SAM. The E2E is not efficacious in preventing long-term recurrent MR if performed for residual MR after complex mitral repair. (Ann Thorac Surg 2006;81:1612 7) 2006 by The Society of Thoracic Surgeons Myxomatous degeneration of the mitral valve is the most common etiology of mitral regurgitation (MR) in developed countries. The benefits of repairing the regurgitant mitral valve over replacement include improved long-term survival and better preservation of left ventricular function, as well as greater freedom from endocarditis, thromboembolism, and anticoagulantrelated hemorrhage [1 6]. Repair may be technically challenging in the face of complex MR, especially when there is a large anterior mitral leaflet or bileaflet prolapse with Barlow s syndrome. The potential for creating systolic anterior motion (SAM) of the anterior mitral leaflet and consequent obstruction of the left ventricular outflow tract (LVOT) can also add significant morbidity and the need for a second exposure to cardiopulmonary bypass (CPB). Although the standard mitral valve repair techniques, including leaflet resection, leaflet advancement, chordal shortening, and insertion of an annuloplasty ring are usually sufficient, the edge-to-edge technique (E2E) has been advocated for eliminating residual MR that occasionally occurs after complex repair of the myxomatous valve [7 9]. We postulated that use of the E2E technique might also be appropriate when there is high risk for developing SAM based on pre-bypass echocardiographic criteria or when it develops postrepair. This report describes our early and medium term experience with the E2E technique in myxomatous mitral valve repair in those patients with high SAM potential, postoperative SAM, and those in whom the E2E technique was used for persistent MR after complicated MV repair without SAM. Patients and Methods Patients The Partners Institutional Review Board approved this clinical study in September All patients included in the study signed a consent form allowing collection and use of their records. From June 1997 to December 2003, 1,612 MV repairs were performed at Brigham and Women s Hospital. Of these, 72 (4.5%) patients had repair of a myxomatous mitral valve for which the E2E technique was applied. Of 72 patients, 52 (72%) had persistent leak after a complex repair (group I); and 20 of 72 patients (28%) had either Accepted for publication Dec 1, Address correspondence to Dr Cohn, Division of Cardiac Surgery, Brigham and Women s Hospital, 75 Francis Street, Boston, MA 02115; lcohn@partners.org. This article has been selected for the open discussion forum on the CTSNet Web Site: org/sections/newsandviews/discussions/index.html 2006 by The Society of Thoracic Surgeons /06/$32.00 Published by Elsevier Inc doi: /j.athoracsur

2 Ann Thorac Surg BRINSTER ET AL 2006;81: EDGE-TO-EDGE TECHNIQUE IMPROVES OUTCOME OF MVR Table 1. Clinical Data No SAM Group I (n 52) SAM Group Group II (n 20) Male 32/52 (62%) 15/20 (75%) Age LVEF NYHA Reoperation 1/20 (5%) 2/52 (4%) LVEF left ventricular ejection fraction; NYHA New york Heart Association; SAM systolic anterior motion. high SAM potential assessed by transesophageal echocardiography (TEE) intraoperatively or severe SAM after CPB (group II). The mean age was years, 47 were male, the average New York Heart Association (NYHA) functional class at admission was , and the average ejection fraction was 56 12%. Three patients (3/72) underwent reoperative mitral valve surgery. The clinical data by group are summarized in Table 1. Mitral regurgitation was graded on a scale of 0 to 4 based on echocardiographic measurements. All patients had 3 to 4 MR before surgery (mean ). The pathology of the MR in all 72 patients is summarized in Table 2. The MR was assessed using preoperative transthoracic echocardiography (TTE), intraoperative TEE, and postoperative TTE. Follow-up data were acquired using patient chart review, phone interview, and postoperative TTE reports. Follow-up was complete in 92% of patients, with a mean follow-up of 1.1 years (range, 1 month to 4 years). Statistics The statistical software package, STATA 7.0 for Windows (STATA, College Station, TX), was used to calculate the data in this report. Operative Details The operative details are summarized in Table 3. The operative approach to mitral valve repair was through the left atrium by Sondergaard s groove after establishing CPB. The valve was inspected intraoperatively to confirm the echocardiographic findings and to identify any additional lesions. The majority of patients underwent a posterior leaflet quadrangular resection with a modified sliding annuloplasty. All patients received a prosthetic annuloplasty ring. The average ring size was 33 4 mm for group I and 35 2 mm for group II (Table 3). Table 2. Pathology of Mitral Regurgitation Pathology No SAM Group I (n 52) SAM Group Group II (n 20) Dilated annulus Anterior leaflet prolapse 8 0 Posterior leaflet prolapse Anterior and posterior leaflet prolapse 22 5 SAM systolic anterior motion. Table 3. Operative Details Repair No. SAM Group I (n 52) SAM Group Group II (n 20) Myxomatous valves Commissuroplasty 7 7 Posterior leaflet resection Leaflet advancement MVP with ring Type of Ring Carbomedics 2 0 Carpentier 5 0 Cosgrove Duran 1 0 Average ring size 33 4mm 35 2mm MVP mitral valve repair; SAM systolic anterior motion. The E2E repair was used in two principal circumstances: group I to correct complex MR jets in 52 of 72 patients in whom a combination of the standard repair techniques were used, and group II to prevent SAM or correct severe SAM in 20 of 72 patients. In group I, a single figure-of-8 E2E stitch with 3-0 Ethibond (Johnson Table 4. AM1 and AM2 Leaflet Lengths (mm) 1613 Patients (group II) AM1 AM High AL strut cord insert AL/PL 1.3 (Maslow) Mean STD Median Probability of asymmetry by paired 2-tailed t test AM1 vs AM AL/PL anterior leaflet to posterior leaflet ratio; AM1 A2 anterolateral segment; AM2 A2 posteriomedial segment; STD standard. CARDIOVASCULAR

3 CARDIOVASCULAR 1614 BRINSTER ET AL Ann Thorac Surg EDGE-TO-EDGE TECHNIQUE IMPROVES OUTCOME OF MVR 2006;81: Fig. 1. The SAM after mitral valve repair. The SAM developed on initial separation from cardiopulmonary bypass after mitral valvuloplasty and Cosgrove annuloplasty ring for flail PM2. Preoperatively (A), marked asymmetry between AM1 (37 mm) and AM2 (32 mm) was apparent, as well as a C-septal distance of 19 mm. Although the height of the posterior mitral leaflet is reduced to 0.9 cm, SAM was noted postbypass in (B). In (C), the E2E suture relieved SAM and the associated mitral regurgitation (MR) seen in (B). (AM1 A2 anterolateral segment; AM2 A2 posteriomedial segment; C-Sept interventricular septum distance; E2E edge-to-edge; PM posterior medial; SAM systolic anterior motion; TEE transesophageal echocardiography.) and Johnson, Piscataway, NJ) was placed at the location of the persistent regurgitant jet. Mitral valve calipers were used to ensure that each of the two residual orifice areas was greater than 2 cm 2. In group II, the E2E stitch was placed to prevent SAM of the anterior mitral leaflet in the left ventricular outflow tract (LVOT) at the coaptation point of A2 and P2. This group included 2 patients with SAM who were identified by TEE after initial termination of CPB (Fig 1). In 18 of 20 patients, SAM potential was determined by intraoperative pre-repair TEE assessment of the mitral valve before CPB was instituted. SAM Potential The mitral valve was determined to have SAM potential based on evaluation of the leaflets, as well as the interaction between the anterior leaflet and the subvalvular apparatus. In 1999, Maslow and colleagues [10] proposed a formula for predicting the risk of SAM using anterior (AL) and posterior (PL) leaflet length, annular diameter, and the ratio between AL and PL (AL/PL ratio). When these measurements are combined with the shortest distance between the mitral valve (MV) coaptation point and the interventricular septum (C-Sept distance), so-called SAM potential can be quantified. Valves with a low AL/PL ratio less than 1.3 and C-Sept distance less than 2.5 cm were considered to have a moderate risk of developing SAM [10]. Most important,valves with asymmetry of the AL greater than 5 mm, in which the A2 anterolateral segment (AM1) was larger than the A2 posteriomedial segment (AM2), were considered to have a moderateto-high risk of SAM with risk proportional to the degree of asymmetry (Fig 2 and Table 4). Results There was no operative mortality in either group. The degree of correction of MR evident on preoperative echocardiography compared with immediate postoperative echocardiography data was statistically significant (p ). The average degree of mitral regurgitation in the immediate postoperative period was Postoperative functional status improved significantly; the mean NYHA improved from preoperatively to postoperatively, with a mean follow-up of 388 days. There were two late deaths in group I. One patient died from a stroke one year after surgery, and the other patient died 3 months after surgery from unknown cause. The development of late MR was assessed in the postoperative period by routine follow-up TTE assessment. For those who had E2E repair for myxomatous MR (MMR), 15 of 52 patients (30%) developed 2 MR in the late postoperative period. All patients with follow-up

4 BRINSTER ET AL EDGE-TO-EDGE TECHNIQUE IMPROVES OUTCOME OF MVR 1615 Fig 2. The systolic anterior motion (SAM) potential pre and post edge-to-edge (E2E) repair. This figure demonstrates a valve with high SAM potential pre and post E2E repair in a patient with Barlow s myxomatous degenerated mitral valve. Panels A, B, and C demonstrate the measurements that are considered in determining the degree of SAM potential. Panel A shows a markedly enlarged annulus diameter and a coaptation point to septal distance (C-Sept) of 2.1 cm. The C-Sept values less than 2.4 cm contribute to SAM potential. Panel B demonstrates the ratio of the anterior and posterior leaflet lengths (AL/PL). The AL/PL ratio 1.3 or less contributes to SAM potential. The full length of AL and PL and not just annulus to coaptation distance is measured. Panel C demonstrates anterior leaflet length in AM1 of 3.38 cm and relative to AM2 of 3.31 cm (panel B). Thus AM1 is 3 mm longer than AM2, another factor predictive of SAM. Panel D shows the postoperative result (trace mitral regurgitation [MR] and no SAM) after a repair that included sliding valvuloplasties of the right and left portions of P2, Cosgrove ring annuloplasty, and an E2E repair placed between PM1 and AM1. Note that there was no mitral stenosis. (AM1 A2 anterolateral segment; AM2 A2 posteriomedial segment.; LA left anterior; LV left ventricular; LVOT left ventricular outflow; MVP mitral valve repair; RV right ventricular; TEE transesophageal echocardiography.) greater than 3 years had developed moderate-to-severe MR (Fig 3). The presence of mitral stenosis (MS) was also assessed by TTE postoperatively. Mild postoperative stenosis developed in 5 patients (7%), moderate MS developed in 2 patients (3%), and 4 patients (6%) developed severe MS ( 10 mm Hg) after surgery. All four patients who required reoperation were the patients who developed severe MS post-repair in all in group I. Two of the four patients required early reoperation ( 30 days from original surgery) to correct their MS. Of the patients who had the E2E repair performed for high SAM potential (group II), no patient developed MS and none developed SAM or progressive MR on postoperative follow-up echocardiography. The freedom from reoperation was 95% at 4 years for group I and 100% for group 2 (Fig 4). Comment Myxomatous mitral valve regurgitation is best treated by repair rather than replacement because of the retention of the normal mitral subvalvular apparatus. While most valves can be adequately treated by conventional repair techniques, in patients with complex mitral valve and persistent MR or those repairs at high risk for the development of SAM the E2E repair has been suggested to be a beneficial adjunct [11]. In our study, the use of the E2E repair as an adjunct to mitral valve repair had a zero in-hospital mortality rate and low late mortality rate. The early postoperative TTE data demonstrated significant improvement in regurgitation and all patients had an improvement in NYHA status. The lack of long-term durability of this repair type in patients with MMR without SAM (group I) is noteworthy. While other studies have suggested durable results of the E2E repair [12], our findings indicate a progression to moderate or severe MR in all patients followed for greater than three years postoperatively who had E2E suture for residual MR. The progression of MR postoperatively could be related to a number of factors, including further degeneration of the valve, poor durability of the E2E technique due to high stress on the leaflet repair, or progressive annular dilation [13]. Because follow-up echocardiograms were primarily transthoracic studies performed at multiple centers, CARDIOVASCULAR Ann Thorac Surg 2006;81:1612 7

5 CARDIOVASCULAR 1616 BRINSTER ET AL Ann Thorac Surg EDGE-TO-EDGE TECHNIQUE IMPROVES OUTCOME OF MVR 2006;81: Fig 3. Kaplan-Meier survival curve. Freedom from the development of late mitral regurgitation (MR) in patients with post-bypass MR. detailed evaluation of the exact failure mechanisms was not possible. These findings are significant, and should be compared with findings after new percutaneous repair device implantation [14]. The use of E2E to prevent post-repair SAM was recently described by Mascagni and colleagues [15] in four patients. In our study, we used pre- and post-bypass TEE to assess high SAM potential in 18 patients. Other groups have identified predictors of SAM to include a redundant anterior leaflet, a long myxomatous posterior leaflet, and anterior displacement of coaptation surfaces into the LVOT [10, 11, 16 20]. On the basis of certain predictive pre-repair characteristics, an E2E repair was used prophylactically to prevent the development of SAM postrepair. All patients undergoing the E2E repair for high SAM potential had no SAM post-repair and did not Fig 5. Mitral anterior leaflet measurement for the prediction of systolic anterior motion. The surgeon s view of the mitral valve is shown with the left side being the anterior lateral (AL) and the right being posterior medial (PM) aspects of the valve. The central scallop of the anterior leaflet is divided in half. The AL side being termed AM1 and the PM side termed AM2. Measurement of the individual lengths of AM1 and AM2 can be easily determined by transesophageal echocardiography and are the distances between the aortic annulus and the tip of the leaflet for each valve segment. When AM1 is greater than 5 mm longer than AM2, systolic anterior motion potential is high. develop mitral stenosis. In two patients early in the series who did develop SAM post-repair, the E2E repair successfully completely reduced SAM. This study suggests that the use of the E2E repair may eliminate SAM post-repair in patients with pre-repair echo findings that suggest a high probability of SAM. The use of E2E repair in this group was not associated with long-term mitral regurgitation or stenosis. The analysis and quantification of the predictive value of the various components of our SAM assessment protocol require further prospective study (Fig 5). Fig 4. Freedom from reoperation. References 1. Yun KL, Miller DC. Mitral valve repair versus replacement. Cardiol Clin 1991;9: Sand ME, Naftel DC, Blackstone EH, Kirklin JW, Karp RB. A comparison of repair and replacement for mitral valve incompetence. J Thorac Cardiovasc Surg 1987;94: Perier P, Deloche A, Chauvaud S, et al. Comparative evaluation of mitral valve repair and replacement with Starr, Bjork, and porcine valve prostheses. Circulation 1984;70:I Lawrie GM. Mitral valve repair vs replacement. Current recommendations and long-term results. Cardiol Clin 1998; 16: Goldsmith IR, Lip GY, Patel RL. A prospective study of changes in the quality of life of patients following mitral valve repair and replacement. Eur J Cardiothorac Surg 2001;20: Cohn LH, Couper GS, Aranki SF, Rizzo RJ, Kinchla NM, Coolins JJ Jr. Long-term results of mitral valve reconstruction for regurgitation of the myxomatous mitral valve. J Thorac Cardiovasc Surg 1994;107: Maisano F, Caldarola A, Blasio A, De Bonis M, La Canna G, Alfieri O. Midterm results of edge-to-edge mitral valve

6 Ann Thorac Surg BRINSTER ET AL 2006;81: EDGE-TO-EDGE TECHNIQUE IMPROVES OUTCOME OF MVR repair without annuloplasty. J Thorac Cardiovasc Surg 2003; 126: Alfieri O, Maisano F, De Bonis M, et al. The double-orifice technique in mitral valve repair: a simple solution for complex problems. J Thorac Cardiovasc Surg 2001;122: Gillinov AM, Cosgrove DM, Blackstone EH, et al. Durability of mitral valve repair for degenerative disease. J Thorac Cardiovasc Surg 1998;116: Maslow AD, Regan MM, Haering JM, Johnson RG, Levine RA. Echocardiographic predictors of left ventricular outflow tract obstruction and systolic anterior motion of the mitral valve after mitral valve reconstruction for myxomatous valve disease. J Am Coll Cardiol 1999;34: Lee KS, Stewart WJ, Lever HM, Underwood PL, Cosgrove DM. Mechanism of outflow tract obstruction causing failed mitral valve repair. Anterior displacement of leaflet coaptation. Circulation 1993;88:II Maisano F, Torracca L, Oppizzi M, et al. The edge-to-edge technique: a simplified method to correct mitral insufficiency. Eur J Cardiothorac Surg 1998;13:240 5; discussion Bhudia SK, McCarthy PM, Smedira NG, Lam BK, Rajeswaran J, Blackstone EH. Edge-to-edge (Alfieri) mitral repair: results in diverse clinical settings. Ann Thorac Surg 2004;77: Vassiliades TA Jr, Block PC, Cohn LH, et al. The clinical development of percutaneous heart valve technology. J Thorac Cardiovasc Surg 2005;129: Mascagni R, Al Attar N, Lamarra M, et al. Edge-to-edge technique to treat post-mitral valve repair systolic anterior motion and left ventricular outflow tract obstruction. Ann Thorac Surg 2005;79:471 3; discussion Grossi EA, Steinberg BM, LeBoutillier M III, et al. Decreasing incidence of systolic anterior motion after mitral valve reconstruction. Circulation 1994;90:II Obadia JF, Janier M. Second order anterior mitral leaflets play a role in preventing systolic anterior motion. Ann Thorac Surg 2002;73: ; author reply Timek TA, Nielsen SL, Green GR, et al. Influence of anterior mitral leaflet second-order chordae on leaflet dynamics and valve competence. Ann Thorac Surg 2001;72:535 40; discussion Timek TA, Green GR, Tibayan FA, et al. Aorto-mitral annular dynamics. Ann Thorac Surg. 2003;76: Goetz WA, Lim HS, Lansac E, Weber PA, Birnbaum DE, Duran CM. The aortomitral angle is suspended by the anterior mitral basal stay chords. Thorac Cardiovasc Surg 2003;51: CARDIOVASCULAR INVITED COMMENTARY The authors [1] conclude that the edge-to-edge technique is not efficacious in preventing recurrent mitral regurgitation or stenosis if performed for peroperative residual mitral regurgitation. However, in my opinion there is another way to interpret the results: in group 1, the edge-to-edge technique is always used after a mitral valve repair, whereas in group 2 the great majority of the valves were primarily repaired by the edge-to-edge technique (ie, a figure of 8-stitch Ethibond [3 0] [Johnson & Johnson, Ethicon Inc, Sommerville, NY]). The original Alfieri technique is much more than that: the stitches are broad and reach the base of the secondary chordae of the anterior leaflet to initiate a good coaptation for the rest of the valve. This was certainly not achieved in group 1, also probably because of a relative lack of residual leaflet tissue after the attempt of repair; this would also explain the 10% incidence of mitral stenosis, but it might have been better achieved in group 2, which would explain the striking difference in results. The authors are comparing these disappointing results with those published by Alfieri. Yet I do not believe that the authors are allowed to compare a bail-out technique with a primary one; again the amount of leaflet tissue is completely different before and after an attempt to correct a Barlow disease. The authors apply a sophisticated algorithm to identify patients having a high propensity to systolic anterior motion (SAM). It certainly works if we consider that the 20 patients of group 2 only represent 1.2 % of the patients having benefited from mitral valve repair during the same time span. However, in our experience it has been possible to keep the incidence of SAM around 1% without using a preventive Alfieri stitch. The height of the posterior leaflet, if excessive, indeed should be reduced from commissure to commissure and not only in the region of P2. Repositioning of the papillary muscle(s) or the use of neochordae in Goretex (W. L. Gore & Associates, Flagstaff, AZ) currently allow the surgeon to decrease the width of the leaflet resection and the extent of annulus plication. The size of the annuloplasty ring should be adapted to the length of the anterior leaflet and even be oversized in presence of Barlow or Marfan disease. When a preoperative SAM is due to an asymmetric hypertrophy of the septum, the anterior leaflet is often paradoxically too short; an alternative to the Alfieri stitch is the debulking of the septal hypertrophy after disinsertion of the anterior leaflet, followed by an enlargement of the anterior leaflet. The authors have to be congratulated for producing an important article in a difficult surgical field. They have certainly confirmed that the edge-to-edge technique is successful in correcting a post-repair SAM, and they have validated their algorithm for the detection of a risk for a postoperative SAM. Worrisome is their finding that the edge-to-edge technique is less successful when used as a bail out after a failing repair, which is in fact the indication of the edge-to-edge technique for many surgeons. However, is the Alfieri stitch maybe still useful when there is still enough leaflet tissue? Robert Dion, MD Leids Universitair Medisch Centrum Albinusdreef 2 PO Box RC Leiden, 2333 ZA, the Netherlands r.a.e.dion@lumc.nl Reference 1. Brinster DR, Unic D, D Ambra MN, Nathan N, Cohn LH. Midterm results of the edge-to-edge technique for complex mitral valve repair. Ann Thorac Surg 2006;81: by The Society of Thoracic Surgeons /06/$32.00 Published by Elsevier Inc doi: /j.athoracsur

Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease

Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease TIRONE E. DAVID, MD ; SEMIN THORAC CARDIOVASC SURG 19:116-120c 2007 ELSEVIER INC. PRESENTED BY INTERN 許士盟 Mitral valve

More information

The Edge-to-Edge Technique f For Barlow's Disease

The Edge-to-Edge Technique f For Barlow's Disease The Edge-to-Edge Technique f For Barlow's Disease Ottavio Alfieri, Michele De Bonis, Elisabetta Lapenna, Francesco Maisano, Lucia Torracca, Giovanni La Canna. Department of Cardiac Surgery, San Raffaele

More information

Long term outcomes of posterior leaflet folding valvuloplasty for mitral valve regurgitation

Long term outcomes of posterior leaflet folding valvuloplasty for mitral valve regurgitation Featured Article Long term outcomes of posterior leaflet folding valvuloplasty for mitral valve regurgitation Igor Gosev 1, Maroun Yammine 1, Marzia Leacche 1, Siobhan McGurk 1, Vladimir Ivkovic 1, Michael

More information

Χειρουργική Αντιμετώπιση της Ανεπάρκειας της Μιτροειδούς Βαλβίδας

Χειρουργική Αντιμετώπιση της Ανεπάρκειας της Μιτροειδούς Βαλβίδας Χειρουργική Αντιμετώπιση της Ανεπάρκειας της Μιτροειδούς Βαλβίδας Dr Χρήστος ΑΛΕΞΙΟΥ MD, PhD, FRCS(Glasgow), FRCS(CTh), CCST(UK) Consultant Cardiothoracic Surgeon Normal Mitral Valve Function Mitral Regurgitation

More information

THE FOLDING LEAFLET. Rafael García Fuster. Cardiac Surgery Department University General Hospital of Valencia

THE FOLDING LEAFLET. Rafael García Fuster. Cardiac Surgery Department University General Hospital of Valencia THE FOLDING LEAFLET Rafael García Fuster Cardiac Surgery Department University General Hospital of Valencia School of Medicine Catholic University of Valencia San Vicente Mártir SPAIN Carpentier s principles

More information

The Key Questions in Mitral Valve Interventions. Where Are We in 2018?

The Key Questions in Mitral Valve Interventions. Where Are We in 2018? The Key Questions in Mitral Valve Interventions Where Are We in 2018? Gilles D. DREYFUS, MD, FRCS, FESC Professor of Cardiothoracic Surgery 30 GIORNATE CARDIOLOGICHE TORINESI - OCT 2018 Are guidelines

More information

Posterior leaflet prolapse is the most common lesion seen

Posterior leaflet prolapse is the most common lesion seen Techniques for Repairing Posterior Leaflet Prolapse of the Mitral Valve Robin Varghese, MD, MS, and David H. Adams, MD Posterior leaflet prolapse is the most common lesion seen in degenerative mitral valve

More information

Valve Analysis and Pathoanatomy: THE MITRAL VALVE

Valve Analysis and Pathoanatomy: THE MITRAL VALVE : THE MITRAL VALVE Marc R. Moon, M.D. John M. Shoenberg Chair in CV Disease Chief, Cardiac Surgery Washington University School of Medicine, St. Louis, MO Secretary, American Association for Thoracic Surgery

More information

Surgical Repair of the Mitral Valve Presenter: Graham McCrystal Cardiothoracic Surgeon Christchurch Public Hospital

Surgical Repair of the Mitral Valve Presenter: Graham McCrystal Cardiothoracic Surgeon Christchurch Public Hospital Mitral Valve Surgical intervention Graham McCrystal Chairs: Rajesh Nair & Gerard Wilkins Surgical Repair of the Mitral Valve Presenter: Graham McCrystal Cardiothoracic Surgeon Christchurch Public Hospital

More information

Bulging Subaortic Septum: An Important Risk Factor for Systolic Anterior Motion After Mitral Valve Repair

Bulging Subaortic Septum: An Important Risk Factor for Systolic Anterior Motion After Mitral Valve Repair Bulging Subaortic Septum: An Important Risk Factor for Systolic Anterior Motion After Mitral Valve Repair Sameh M. Said, MD, Hartzell V. Schaff, MD, Rakesh M. Suri, MD, DPhil, Kevin L. Greason, MD, Joseph

More information

Long-Term Assessment of Mitral Valve Reconstruction With Resection of the Leaflets: Triangular and Quadrangular Resection

Long-Term Assessment of Mitral Valve Reconstruction With Resection of the Leaflets: Triangular and Quadrangular Resection Long-Term Assessment of Mitral Valve Reconstruction With Resection of the Leaflets: Triangular and Quadrangular Resection Yoshimasa Sakamoto, MD, Kazuhiro Hashimoto, MD, Hiroshi Okuyama, MD, Shinichi Ishii,

More information

Surgery for Valvular Heart Disease. Very Long-Term Survival and Durability of Mitral Valve Repair for Mitral Valve Prolapse

Surgery for Valvular Heart Disease. Very Long-Term Survival and Durability of Mitral Valve Repair for Mitral Valve Prolapse Surgery for Valvular Heart Disease Very Long-Term Survival and Durability of Mitral Valve Repair for Mitral Valve Prolapse Dania Mohty, MD; Thomas A. Orszulak, MD; Hartzell V. Schaff, MD; Jean-Francois

More information

Journal of the American College of Cardiology Vol. 34, No. 7, by the American College of Cardiology ISSN /99/$20.

Journal of the American College of Cardiology Vol. 34, No. 7, by the American College of Cardiology ISSN /99/$20. Journal of the American College of Cardiology Vol. 34, No. 7, 1999 1999 by the American College of Cardiology ISSN 0735-1097/99/$20.00 Published by Elsevier Science Inc. PII S0735-1097(99)00464-7 Echocardiographic

More information

Surgical repair techniques for IMR: future percutaneous options?

Surgical repair techniques for IMR: future percutaneous options? Surgical repair techniques for IMR: can this teach us about future percutaneous options? Genk - Belgium Prof. Dr. R. Dion KULeu Disclosure slide Robert A. Dion I disclose the following financial relationships:

More information

Chordae replacement versus leaflet resection in minimally invasive mitral valve repair

Chordae replacement versus leaflet resection in minimally invasive mitral valve repair Perspective Chordae replacement versus leaflet resection in minimally invasive mitral valve repair Tomas Holubec, Simon H. Sündermann, Stephan Jacobs, Volkmar Falk Division of Cardiovascular Surgery, University

More information

Disclosure Statement of Financial Interest Saibal Kar, MD, FACC

Disclosure Statement of Financial Interest Saibal Kar, MD, FACC MitraClip Therapy Saibal Kar, MD, FACC, FAHA, FSCAI Director of Interventional Cardiac Research Program Director, Interventional Cardiology Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA

More information

Recurrent mitral regurgitation after repair: Should the mitral valve be re-repaired?

Recurrent mitral regurgitation after repair: Should the mitral valve be re-repaired? Surgery for Acquired Cardiovascular Disease Recurrent mitral regurgitation after repair: Should the mitral valve be re-repaired? Rakesh M. Suri, MD, DPhil, Hartzell V. Schaff, MD, Joseph A. Dearani, MD,

More information

Technical aspects of robotic posterior mitral valve leaflet repair

Technical aspects of robotic posterior mitral valve leaflet repair rt of Operative Techniques Technical aspects of robotic posterior mitral valve leaflet repair Hoda Javadikasgari, Rakesh M. Suri, Tomislav Mihaljevic, Stephanie Mick,. Marc Gillinov Department of Thoracic

More information

Atrioventricular valve repair: The limits of operability

Atrioventricular valve repair: The limits of operability Atrioventricular valve repair: The limits of operability Francis Fynn-Thompson, MD Co-Director, Center for Airway Disorders Surgical Director, Pediatric Mechanical Support Program Surgical Director, Heart

More information

Evolution of the concept and practice of mitral valve repair

Evolution of the concept and practice of mitral valve repair Keynote Lecture Series Evolution of the concept and practice of mitral valve repair Lawrence H. Cohn 1, Vakhtang Tchantchaleishvili 1,2, Taufiek K. Rajab 1 1 Brigham and Women s Hospital, Harvard Medical

More information

8/31/2016. Mitraclip in Matthew Johnson, MD

8/31/2016. Mitraclip in Matthew Johnson, MD Mitraclip in 2016 Matthew Johnson, MD 1 Abnormal Valve Function Valve Stenosis Obstruction to valve flow during that phase of the cardiac cycle when the valve is normally open. Hemodynamic hallmark - pressure

More information

(Ann Thorac Surg 2008;85:845 53)

(Ann Thorac Surg 2008;85:845 53) I Made Adi Parmana The utility of intraoperative TEE has become increasingly more evident as anesthesiologists, cardiologists, and surgeons continue to appreciate its potential application as an invaluable

More information

MitraClip in the ICCU: Which Patient will Benefit?

MitraClip in the ICCU: Which Patient will Benefit? MitraClip in the ICCU: Which Patient will Benefit? DAVID MEERKIN STRUCTURAL A ND CONGENITAL HEART DISEASE UNIT SHAARE ZEDEK MEDICAL CENTER JERUSALEM Conflict of Interest No relevant disclosures Complex

More information

Percutaneous Mitral Valve Repair

Percutaneous Mitral Valve Repair Indiana Chapter of ACC November 15 th,2008 Percutaneous Mitral Valve Repair James B Hermiller, MD, FACC The Care Group, LLC St Vincent Hospital Indianapolis, IN Mechanisms of Mitral Regurgitation Mitral

More information

Hani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz

Hani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz Hani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia Decision process for

More information

Organic mitral regurgitation

Organic mitral regurgitation The best in heart valve disease Organic mitral regurgitation Ewa Szymczyk Department of Cardiology Medical University of Lodz, Poland I have nothing to declare Organic mitral regurgitation leaflet abnormality

More information

Degenerative mitral valve disease is the leading cause of

Degenerative mitral valve disease is the leading cause of Recurrence of Mitral Valve Regurgitation After Mitral Valve Repair in Degenerative Valve Disease Willem Flameng, MD, PhD; Paul Herijgers, MD, PhD; Kris Bogaerts, MSc Background Durability assessment of

More information

The clinical problem of atrioventricular valve regurgitation

The clinical problem of atrioventricular valve regurgitation Mitral Regurgitation in Congenital Heart Defects: Surgical Techniques for Reconstruction Richard G. Ohye Mitral valve regurgitation (MR) is an important source of morbidity and mortality worldwide. While

More information

Despite advances in our understanding of the pathophysiology

Despite advances in our understanding of the pathophysiology Suture Relocation of the Posterior Papillary Muscle in Ischemic Mitral Regurgitation Benjamin B. Peeler MD,* and Irving L. Kron MD,*, *Department of Cardiovascular Surgery, University of Virginia, Charlottesville,

More information

Management of Incomplete Initial Repair in the Treatment of Degenerative Mitral Insufficiency An Institutional Protocol and Mid-Term Outcomes

Management of Incomplete Initial Repair in the Treatment of Degenerative Mitral Insufficiency An Institutional Protocol and Mid-Term Outcomes CLINICAL STUDY Management of Incomplete Initial Repair in the Treatment of Degenerative Mitral Insufficiency An Institutional Protocol and Mid-Term Outcomes Wenrui Ma, 1 MD, Wei Shi, 1 MD, Wei Zhang, 1

More information

Echocardiographic Evaluation of Primary Mitral Regurgitation

Echocardiographic Evaluation of Primary Mitral Regurgitation Echocardiographic Evaluation of Primary Mitral Regurgitation Roberto M Lang, MD 0-10 o ME 4CH Med A2 P2 50-70 o Commissural P3 P1 A2 80-100 o ME 2CH P3 A2 A1 A1 125-135 o - ME Long axis P2 A2 P3 A3 P2

More information

Valve Repair for Mitral Regurgitation Caused by Isolated Prolapse of the Posterior Leaflet

Valve Repair for Mitral Regurgitation Caused by Isolated Prolapse of the Posterior Leaflet Valve Repair for Mitral Regurgitation Caused by Isolated Prolapse of the Posterior Leaflet Patrick Perier, MD, J/2rgen Stumpf, MD, Christian GStz, MD, Fitsoum Lakew, MD, Andr6 Schneider, MD, Bernd Clausnizer,

More information

What Is the Best Surgical Treatment for Obstructive Hypertrophic Cardiomyopathy and Degenerative Mitral Regurgitation?

What Is the Best Surgical Treatment for Obstructive Hypertrophic Cardiomyopathy and Degenerative Mitral Regurgitation? What Is the Best Surgical Treatment for Obstructive Hypertrophic Cardiomyopathy and Degenerative Mitral Regurgitation? ADULT CARDIAC Calvin K. N. Wan, MD, Joseph A. Dearani, MD, Thoralf M. Sundt III, MD,

More information

Overview of Surgical Approach to Mitral Valve Disease : Why Repair? Steven F. Bolling, MD Cardiac Surgery University of Michigan

Overview of Surgical Approach to Mitral Valve Disease : Why Repair? Steven F. Bolling, MD Cardiac Surgery University of Michigan Overview of Surgical Approach to Mitral Valve Disease : Why Repair? Steven F. Bolling, MD Cardiac Surgery University of Michigan Degenerative MR is not Functional MR 2o - Functional MR : Ventricular Problem!!

More information

The use of mitral valve (MV) repair to correct mitral

The use of mitral valve (MV) repair to correct mitral Outcomes and Long-Term Survival for Patients Undergoing Repair Versus Effect of Age and Concomitant Coronary Artery Bypass Grafting Vinod H. Thourani, MD; William S. Weintraub, MD; Robert A. Guyton, MD;

More information

New Technique for Aortic Valve Functional Annulus Reshaping Using a Handmade Prosthetic Ring

New Technique for Aortic Valve Functional Annulus Reshaping Using a Handmade Prosthetic Ring New Technique for Aortic Valve Functional Annulus Reshaping Using a Handmade Prosthetic Ring Khalil Fattouch, MD, PhD, Roberta Sampognaro, MD, Giuseppe Speziale, MD, and Giovanni Ruvolo, MD Department

More information

Professor and Chief, Division of Cardiac Surgery Chief Medical Officer, Harpoon Medical. The Houston Aortic Symposium February 23-25, 2017

Professor and Chief, Division of Cardiac Surgery Chief Medical Officer, Harpoon Medical. The Houston Aortic Symposium February 23-25, 2017 James S. Gammie, MD Professor and Chief, Division of Cardiac Surgery Chief Medical Officer, Harpoon Medical The Houston Aortic Symposium February 2-25, 2017 Disclosure Statement of Financial Interest Within

More information

Σεμινάρια Ομάδων Εργασίας 2017 Ανεπάρκεια μιτροειδούς μυξωματώδους αιτιολογίας

Σεμινάρια Ομάδων Εργασίας 2017 Ανεπάρκεια μιτροειδούς μυξωματώδους αιτιολογίας Σεμινάρια Ομάδων Εργασίας 2017 Ανεπάρκεια μιτροειδούς μυξωματώδους αιτιολογίας Μυτάς Δημήτρης MD, PhD Επιμ Α ΕΣΥ Σισμανόγλειο Γενικό Νοσοκομείο Αττικής Δηλώνω υπεύθυνα ότι η παρούσα ομιλία δεν επιχορηγείται

More information

Cases of mitral valve causing mitral regurgitation: the MV prolapse spectrum CASE

Cases of mitral valve causing mitral regurgitation: the MV prolapse spectrum CASE Cases of mitral valve causing mitral regurgitation: the MV prolapse spectrum Judy Hung, MD Cardiology Division Massachusetts General Hospital Boston, MA CASE Mr. M; 50 Year male presents to internist for

More information

Quality Outcomes Mitral Valve Repair

Quality Outcomes Mitral Valve Repair Quality Outcomes Mitral Valve Repair Moving Beyond Reoperation Rakesh M. Suri, D.Phil. Professor of Surgery 2015 MFMER 3431548-1 Disclosure Mayo Clinic Division of Cardiovascular Surgery Research funding

More information

The benefits of mitral valve reconstruction for operative

The benefits of mitral valve reconstruction for operative Prophylactic Mitral Reconstruction for Mitral Regurgitation Iva A. Smolens, MD, Francis D. Pagani, MD, PhD, G. Michael Deeb, MD, Richard L. Prager, MD, Seema S. Sonnad, PhD, and Steven F. Bolling, MD Section

More information

Late secondary TR after left sided heart disease correction: is it predictibale and preventable

Late secondary TR after left sided heart disease correction: is it predictibale and preventable Late secondary TR after left sided heart disease correction: is it predictibale and preventable Gilles D. Dreyfus Professor of Cardiothoracic surgery Nath J, et al. JACC 2004 PREDICT Incidence of secondary

More information

Comparison of outcomes of minimally invasive mitral valve surgery for posterior, anterior and bileaflet prolapse

Comparison of outcomes of minimally invasive mitral valve surgery for posterior, anterior and bileaflet prolapse European Journal of Cardio-thoracic Surgery 36 (2009) 532 538 www.elsevier.com/locate/ejcts Comparison of outcomes of minimally invasive mitral valve surgery for posterior, anterior and bileaflet prolapse

More information

The risk-benefit ratio of mitral valve operation is

The risk-benefit ratio of mitral valve operation is Degenerative Mitral Regurgitation: When Should We Operate? Malcolm J. R. Dalrymple-Hay, PhD, Mark Bryant, Richard A. Jones, MRCP, Stephen M. Langley, FRCS, Steven A. Livesey, FRCS, and James L. Monro,

More information

Mitral Valve Repair for Functional Mitral Regurgitation- Description of A New Technique and Classification System

Mitral Valve Repair for Functional Mitral Regurgitation- Description of A New Technique and Classification System Case Report Mitral Valve Repair for Functional Mitral Regurgitation- Description of A New Technique and Classification System Antonio Chiricolo 1*, Leonard Y Lee 2 1 Department of Anesthesiology, Rutgers

More information

Hani K. Najm MD, Msc, FRCSC, FRCS (Glasgow), FACC, FESC President of Saudi Heart Association King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia.

Hani K. Najm MD, Msc, FRCSC, FRCS (Glasgow), FACC, FESC President of Saudi Heart Association King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia. Hani K. Najm MD, Msc, FRCSC, FRCS (Glasgow), FACC, FESC President of Saudi Heart Association King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia. Decision process for Management of any valve Timing Feasibility

More information

Repair or Replacement

Repair or Replacement Surgical intervention post MitraClip Device: Repair or Replacement Saudi Heart Association, February 21-24 Rüdiger Lange, MD, PhD Nicolo Piazza, MD, FRCPC, FESC German Heart Center, Munich, Germany Division

More information

Mitral valve repair is the gold standard to treat mitral regurgitation.

Mitral valve repair is the gold standard to treat mitral regurgitation. Papillary muscle repositioning for repair of anterior leaflet prolapse caused by chordal elongation Gilles D. Dreyfus, MD, PhD, FRCS, Olivio Souza Neto, MD, and Stéphane Aubert, MD, MSc Objective: Anterior

More information

MITRAL REGURGITATION ECHO PARAMETERS TOOL

MITRAL REGURGITATION ECHO PARAMETERS TOOL Comprehensive assessment of qualitative and quantitative parameters, along with the use of standardized nomenclature when reporting echocardiographic findings, helps to better define a patient s MR and

More information

Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat

Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat Innovative Procedures, Devices & State of the Art Care for Arrhythmias, Heart Failure & Structural Heart Disease October 8-10,

More information

Historical perspective R1 黃維立

Historical perspective R1 黃維立 Degenerative mitral valve disease refers to a spectrum of conditions in which morphologic changes in the connective tissue of the mitral valve cause structural lesions that prevent normal function of the

More information

Really Less-Invasive Trans-apical Beating Heart Mitral Valve Repair: Which Patients?

Really Less-Invasive Trans-apical Beating Heart Mitral Valve Repair: Which Patients? Really Less-Invasive Trans-apical Beating Heart Mitral Valve Repair: Which Patients? David H. Adams, MD Cardiac Surgeon-in-Chief Mount Sinai Health System Marie Josée and Henry R. Kravis Professor and

More information

Degenerative mitral valve disease is now the most common

Degenerative mitral valve disease is now the most common Triangular Resection for Repair of Mitral Regurgitation Due to Degenerative Disease Rakesh M. Suri, MD, DPhil, FRCS(C), and Thomas A. Orszulak, MD, FACC Degenerative mitral valve disease is now the most

More information

Chapter 24: Diagnostic workup and evaluation: eligibility, risk assessment, FDA guidelines Ashwin Nathan, MD, Saif Anwaruddin, MD, FACC Penn Medicine

Chapter 24: Diagnostic workup and evaluation: eligibility, risk assessment, FDA guidelines Ashwin Nathan, MD, Saif Anwaruddin, MD, FACC Penn Medicine Chapter 24: Diagnostic workup and evaluation: eligibility, risk assessment, FDA guidelines Ashwin Nathan, MD, Saif Anwaruddin, MD, FACC Penn Medicine Mitral regurgitation, regurgitant flow between the

More information

The correlation between the coaptation height of mitral valve and mitral regurgitation after mitral valve repair

The correlation between the coaptation height of mitral valve and mitral regurgitation after mitral valve repair Wei et al. Journal of Cardiothoracic Surgery (2017) 12:120 DOI 10.1186/s13019-017-0687-0 RESEARCH ARTICLE Open Access The correlation between the coaptation height of mitral valve and mitral regurgitation

More information

Basic Principles of Degenerative Mitral Valve Repair Technical Aspects and Results. Manuel Antunes Coimbra-Portugal

Basic Principles of Degenerative Mitral Valve Repair Technical Aspects and Results. Manuel Antunes Coimbra-Portugal Basic Principles of Degenerative Mitral Valve Repair Technical Aspects and Results Manuel Antunes Coimbra-Portugal Repair for Degenerative Disease Adams D H et al. Eur Heart J 2010;31:1958-1966 Published

More information

KANEKO T et al. Mitral Valve Repair. Evolution and Revolution Tsuyoshi Kaneko, MD; Lawrence H Cohn, MD

KANEKO T et al. Mitral Valve Repair. Evolution and Revolution Tsuyoshi Kaneko, MD; Lawrence H Cohn, MD 560 Circulation Journal KANEKO T et al. Official Journal of the Japanese Circulation Society http://www.j-circ.or.jp Mitral Valve Repair Evolution and Revolution 1923 2013 Tsuyoshi Kaneko, MD; Lawrence

More information

Imaging MV. Jeroen J. Bax Leiden University Medical Center The Netherlands Davos, feb 2015

Imaging MV. Jeroen J. Bax Leiden University Medical Center The Netherlands Davos, feb 2015 Imaging MV Jeroen J. Bax Leiden University Medical Center The Netherlands Davos, feb 2015 MV/MR: information needed on.. 1. MV anatomy 2. MR etiology - primary vs secondary 3. MR severity quantification

More information

Anterior Mitral Leaflet Prolapse as a Primary Cause of Pure Rheumatic Mitral Insufficiency

Anterior Mitral Leaflet Prolapse as a Primary Cause of Pure Rheumatic Mitral Insufficiency Anterior Mitral Leaflet Prolapse as a Primary Cause of Pure Rheumatic Mitral Insufficiency Afksendiyos Kalangos, MD, PhD, Maurice Beghetti, MD, Dominique Vala, MD, Edgar Jaeggi, MD, Gürkan Kaya, MD, Vildan

More information

Haiping Wang 1,2, Xiancheng Liu 2, Xin Wang 2, Zhenqian Lv 2, Xiaojun Liu 2, Ping Xu 1. Introduction

Haiping Wang 1,2, Xiancheng Liu 2, Xin Wang 2, Zhenqian Lv 2, Xiaojun Liu 2, Ping Xu 1. Introduction Original Article Comparison of outcomes of tricuspid annuloplasty with 3D-rigid versus flexible prosthetic ring for functional tricuspid regurgitation secondary to rheumatic mitral valve disease Haiping

More information

Degenerative Mitral Regurgitation: Etiology and Natural History of Disease and Triggers for Intervention

Degenerative Mitral Regurgitation: Etiology and Natural History of Disease and Triggers for Intervention Degenerative Mitral Regurgitation: Etiology and Natural History of Disease and Triggers for Intervention John N. Hamaty D.O. FACC, FACOI November 17 th 2017 I have no financial disclosures Primary Mitral

More information

Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM

Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM The Patient with Aortic Stenosis and Mitral Regurgitation Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM Aortic Stenosis + Mitral Regurgitation?

More information

Basic principles of Rheumatic mitral valve Repair

Basic principles of Rheumatic mitral valve Repair Basic principles of Rheumatic mitral valve Repair Prof. Gebrine El Khoury, MD DEPARTMENT OF CARDIOVASCULAR AND THORACIC SURGERY ST. LUC HOSPITAL - BRUSSELS, BELGIUM 1 Rheumatic MV disease MV repair confers

More information

Index. B B-type natriuretic peptide (BNP), 76

Index. B B-type natriuretic peptide (BNP), 76 Index A ACCESS-EU registry, 158 159 Acute kidney injury (AKI), 76, 88 Annular enlargement, RV, 177 178 Annuloplasty chordal cutting, 113 complete ring, 99 etiology-specific ring, 100 evolution, 98 flexible

More information

Tricuspid leaflet repair: innovative solutions

Tricuspid leaflet repair: innovative solutions Perspective Tricuspid leaflet repair: innovative solutions Jack H. Boyd 1, J. James B. Edelman 2, David H. Scoville 1, Y. Joseph Woo 1 1 Department of Cardiothoracic Surgery, Stanford University School

More information

Mitral Valve Disease, When to Intervene

Mitral Valve Disease, When to Intervene Mitral Valve Disease, When to Intervene Swedish Heart and Vascular Institute Ming Zhang MD PhD Interventional Cardiology Structure Heart Disease Conflict of Interest None Current ACC/AHA guideline Stages

More information

Primary Mitral Valve Disease: Natural History & Triggers for Intervention ACC Latin American Conference 2017

Primary Mitral Valve Disease: Natural History & Triggers for Intervention ACC Latin American Conference 2017 Disclosures: GE stock, Primary Mitral Valve Disease: Natural History & Triggers for Intervention ACC Latin American Conference 2017 Athena Poppas, MD FACC Past ACC Scientific Sessions Chair, ACC Board

More information

Rheumatic fever and rheumatic heart disease still remain a. The Rheumatic Mitral Valve and Repair Techniques in Children. Afksendiyos Kalangos

Rheumatic fever and rheumatic heart disease still remain a. The Rheumatic Mitral Valve and Repair Techniques in Children. Afksendiyos Kalangos The Rheumatic Mitral Valve and Repair Techniques in Children Afksendiyos Kalangos The mitral valve is the most commonly affected valve in acute and chronic rheumatic heart disease in the first and second

More information

Eva Maria Delmo Walter Takeshi Komoda Roland Hetzer

Eva Maria Delmo Walter Takeshi Komoda Roland Hetzer Surgical repair of the congenitally malformed mitral valve leaflets in infants and children Eva Maria Delmo Walter Takeshi Komoda Roland Hetzer Deutsches Herzzentrum Berlin Germany Background and Objective

More information

When should we intervene surgically in pediatric patient with MR?

When should we intervene surgically in pediatric patient with MR? When should we intervene surgically in pediatric patient with MR? DR.SAUD A. BAHAIDARAH CONSULTANT, PEDIATRIC CARDIOLOGY ASSISTANT PROFESSOR OF PEDIATRICS HEAD OF CARDIOLOGY AND CARDIAC SURGERY UNIT KAUH

More information

There is increasing acceptance of the value of reconstructing

There is increasing acceptance of the value of reconstructing Fleur de Lys Repair of Posterior Mitral Valve Leaflet Richard A. Hopkins, MD There is increasing acceptance of the value of reconstructing mitral valves and retaining the various components of the mitral

More information

What s New in Mitral Valve Repair?

What s New in Mitral Valve Repair? Original Article Daniel J. DiBardino, MD R. Saeid Farivar, MD, PhD From: Abbott Northwestern Hospital, Minneapolis, MN Address for correspondence: R. Saeid Farivar, MD, PhD Cardiothoracic Surgery Abbott

More information

Surgery For Ebstein Anomaly

Surgery For Ebstein Anomaly Surgery For Ebstein Anomaly Christian Pizarro, MD Chief, Pediatric Cardiothoracic Surgery Director, Nemours Cardiac Center Alfred I. dupont Hospital for Children Professor of Surgery and Pediatrics Sidney

More information

Minimally invasive valve sparing mitral valve repair the loop technique how we do it

Minimally invasive valve sparing mitral valve repair the loop technique how we do it Art of Operative Techniques Minimally invasive valve sparing mitral valve repair the loop technique how we do it Stephan Jacobs, Simon H. Sündermann Division of Cardiovascular Surgery, University Hospital

More information

Ischemic mitral valve reconstruction and replacement: Comparison of long-term survival and complications

Ischemic mitral valve reconstruction and replacement: Comparison of long-term survival and complications Surgery for Acquired Cardiovascular Disease Ischemic mitral valve reconstruction and replacement: Comparison of long-term survival and complications Eugene A. Grossi, MD Judith D. Goldberg, ScD Angelo

More information

Επιδιόπθωζη μιηποειδικήρ ζςζκεςήρ ζε ππόπηωζη ή πήξη γλωσίνων. Βαζίλειορ Σασπεκίδηρ Επιμεληηήρ Β Καπδιολογίαρ Γ.Ν. Παπαγεωπγίος

Επιδιόπθωζη μιηποειδικήρ ζςζκεςήρ ζε ππόπηωζη ή πήξη γλωσίνων. Βαζίλειορ Σασπεκίδηρ Επιμεληηήρ Β Καπδιολογίαρ Γ.Ν. Παπαγεωπγίος Επιδιόπθωζη μιηποειδικήρ ζςζκεςήρ ζε ππόπηωζη ή πήξη γλωσίνων Βαζίλειορ Σασπεκίδηρ Επιμεληηήρ Β Καπδιολογίαρ Γ.Ν. Παπαγεωπγίος MV anatomy Otto C. NEJM 2001 Leaflets anatomy 2% of population Etiology Terminology

More information

Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement?

Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement? Original Article Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement? Hiroaki Sakamoto, MD, PhD, and Yasunori Watanabe, MD, PhD Background: Recently, some articles

More information

Treatment of Ruptured or Elon ated Anterior Mitral Valve Chordae bv Parti 3 Transposition of the Posterior Leaflet: Experience with 29 Patients

Treatment of Ruptured or Elon ated Anterior Mitral Valve Chordae bv Parti 3 Transposition of the Posterior Leaflet: Experience with 29 Patients Treatment of Ruptured or Elon ated Anterior Mitral Valve Chordae bv Parti 3 Transposition of the Posterior Leaflet: Experience with 29 Patients Arrigo Lessana, M.D., Mauro Romano, M.D., Genevieve Lutfalla,

More information

Challenging Case. 77 year old man 1/24/2018. Two months PTA AVR with 21 Edwards Magna and VSD repair for S. Aureus endocarditis

Challenging Case. 77 year old man 1/24/2018. Two months PTA AVR with 21 Edwards Magna and VSD repair for S. Aureus endocarditis Vumedi January 2018 77 year old man Challenging Case Paul Sorajja, MD Roger L. and Lynn C. Headrick Family Chair Valve Science Center, Minneapolis Heart Institute Foundation Abbott Northwestern Hospital

More information

JOINT MEETING 2 Tricuspid club Chairpersons: G. Athanassopoulos, A. Avgeropoulou, M. Khoury, G. Stavridis

JOINT MEETING 2 Tricuspid club Chairpersons: G. Athanassopoulos, A. Avgeropoulou, M. Khoury, G. Stavridis JOINT MEETING 2 Tricuspid club Chairpersons: G. Athanassopoulos, A. Avgeropoulou, M. Khoury, G. Stavridis Similarities and differences in Tricuspid vs. Mitral Valve Anatomy and Imaging. Echo evaluation

More information

Kinsing Ko, Thom de Kroon, Najim Kaoui, Bart van Putte, Nabil Saouti. St. Antonius Hospital, Nieuwegein, The Netherlands

Kinsing Ko, Thom de Kroon, Najim Kaoui, Bart van Putte, Nabil Saouti. St. Antonius Hospital, Nieuwegein, The Netherlands Minimal Invasive Mitral Valve Surgery After Previous Sternotomy Without Aortic Clamping: Short- and Long Term Results of a Single Surgeon Single Institution Kinsing Ko, Thom de Kroon, Najim Kaoui, Bart

More information

Bicuspid aortic root spared during ascending aorta surgery: an update of long-term results

Bicuspid aortic root spared during ascending aorta surgery: an update of long-term results Short Communication Bicuspid aortic root spared during ascending aorta surgery: an update of long-term results Marco Russo, Guglielmo Saitto, Paolo Nardi, Fabio Bertoldo, Carlo Bassano, Antonio Scafuri,

More information

Value of Augmented Reality-Enhanced Transesophageal Echocardiography (TEE) for Determining Optimal Annuloplasty Ring Size During Mitral Valve Repair

Value of Augmented Reality-Enhanced Transesophageal Echocardiography (TEE) for Determining Optimal Annuloplasty Ring Size During Mitral Valve Repair Value of Augmented Reality-Enhanced Transesophageal Echocardiography (TEE) for Determining Optimal Annuloplasty Ring Size During Mitral Valve Repair Joerg Ender, MD, Jasmina Končar-Zeh, MD, Chirojit Mukherjee,

More information

Septal Myectomy, Papillary Muscle Resection, and Mitral Valve Replacement for Hypertrophic Obstructive Cardiomyopathy: A Case Report

Septal Myectomy, Papillary Muscle Resection, and Mitral Valve Replacement for Hypertrophic Obstructive Cardiomyopathy: A Case Report Case Report Septal Myectomy, Papillary Muscle Resection, and Mitral Valve Replacement for Hypertrophic Obstructive Cardiomyopathy: A Case Report Junichiro Takahashi, MD, 1 Yutaka Wakamatsu, MD, 1 Jun Okude,

More information

When Does 3D Echo Make A Difference?

When Does 3D Echo Make A Difference? When Does 3D Echo Make A Difference? Wendy Tsang, MD, SM Assistant Professor, University of Toronto Toronto General Hospital, University Health Network 1 Practical Applications of 3D Echocardiography Recommended

More information

Ann Thorac Cardiovasc Surg 2015; 21: Online April 18, 2014 doi: /atcs.oa Original Article

Ann Thorac Cardiovasc Surg 2015; 21: Online April 18, 2014 doi: /atcs.oa Original Article Ann Thorac Cardiovasc Surg 2015; 21: 53 58 Online April 18, 2014 doi: 10.5761/atcs.oa.13-00364 Original Article The Impact of Preoperative and Postoperative Pulmonary Hypertension on Long-Term Surgical

More information

Routine MitraClip. Image Guidance Step by Step

Routine MitraClip. Image Guidance Step by Step Routine MitraClip Image Guidance Step by Step Douglas C. Shook, MD, FASE Director, Cardiothoracic Anesthesia Fellowship Director, Cardiac Interventional Anesthesia Department of Anesthesiology BRIGHAM

More information

Which Type of Secondary Tricuspid Regurgitation Accompanying Mitral Valve Disease Should Be Surgically Treated?

Which Type of Secondary Tricuspid Regurgitation Accompanying Mitral Valve Disease Should Be Surgically Treated? Ann Thorac Cardiovasc Surg 2013; 19: 428 434 Online January 31, 2013 doi: 10.5761/atcs.oa.12.01929 Original Article Which Type of Secondary Tricuspid Regurgitation Accompanying Mitral Valve Disease Should

More information

Mitral Gradients and Frequency of Recurrence of Mitral Regurgitation After Ring Annuloplasty for Ischemic Mitral Regurgitation

Mitral Gradients and Frequency of Recurrence of Mitral Regurgitation After Ring Annuloplasty for Ischemic Mitral Regurgitation Mitral Gradients and Frequency of Recurrence of Mitral Regurgitation After Ring Annuloplasty for Ischemic Mitral Regurgitation Matthew L. Williams, MD, Mani A. Daneshmand, MD, James G. Jollis, MD, John

More information

Part II: Fundamentals of 3D Echocardiography: Acquisition and Application

Part II: Fundamentals of 3D Echocardiography: Acquisition and Application Part II: Fundamentals of 3D Echocardiography: Acquisition and Application Dr. Bruce Bollen 3D matrix array TEE probes provide options for both 2D and 3D imaging. Indeed, their utility in obtaining multiple

More information

Research Article Transapical Approach for Mitral Valve Repair during Insertion of a Left Ventricular Assist Device

Research Article Transapical Approach for Mitral Valve Repair during Insertion of a Left Ventricular Assist Device The Scientific World Journal Volume 2013, Article ID 925310, 4 pages http://dx.doi.org/10.1155/2013/925310 Research Article Transapical Approach for Mitral Valve Repair during Insertion of a Left Ventricular

More information

Mitral Valve Abnormalities in Hypertrophic Cardiomyopathy: Echocardiographic Features and Surgical Outcomes

Mitral Valve Abnormalities in Hypertrophic Cardiomyopathy: Echocardiographic Features and Surgical Outcomes Mitral Valve Abnormalities in Hypertrophic Cardiomyopathy: Echocardiographic Features and Surgical Outcomes Ryan K. Kaple, BS, Ross T. Murphy, MD, Linda M. DiPaola, BA, Penny L. Houghtaling, MS, Harry

More information

Prognostic Impact of FMR

Prognostic Impact of FMR Secondary Mitral Valve Regurgitation in Heart Failure, Age 60 Years From Medical Therapy to Surgical Repair to Transcatheter Intervention The Interventionalist s View Samin K Sharma, MD, FACC, FSCAI Director

More information

Mitral valve repair is the treatment of choice for most. Hemolysis After Mitral Valve Repair: Mechanisms and Treatment

Mitral valve repair is the treatment of choice for most. Hemolysis After Mitral Valve Repair: Mechanisms and Treatment Hemolysis After Mitral Valve Repair: Mechanisms and Treatment Buu-Khanh Lam, MD, Delos M. Cosgrove III, MD, Sunil K. Bhudia, MD, and A. Marc Gillinov, MD Department of Thoracic and Cardiovascular Surgery,

More information

Failed Aortic Valve Repairs Lessons Learned

Failed Aortic Valve Repairs Lessons Learned Failed Aortic Valve Repairs Lessons Learned A. Stephane Lambert, MD, FRCPC Munir Boodhwani, MD, MMSc, FRCSC University of Ottawa Heart Institute Ottawa Ontario No Disclosure Why do repairs fail? Basic

More information

Transoesophageal Echocardiographic Evaluation of the Mitral Valve

Transoesophageal Echocardiographic Evaluation of the Mitral Valve 10.5005/jp-journals-10027-1018 REVIEW ARTICLE IJPUT Transoesophageal Echocardiographic Evaluation of the Mitral Valve Gary Lau, Ravi Hebballi ABSTRACT Transoesophageal echocardiography allows the precise

More information

Repair of Congenital Mitral Valve Insufficiency

Repair of Congenital Mitral Valve Insufficiency Repair of Congenital Mitral Valve Insufficiency Roland Hetzer, MD, PhD, and Eva Maria Delmo Walter, MS, MD, PhD Principles of Mitral Valve Repair We believe that mitral valve repair for congenital mitral

More information

Mitral valve surgery has changed considerably in the past decades and is now indicated

Mitral valve surgery has changed considerably in the past decades and is now indicated Valve disease TIMING OF MITRAL VALVE SURGERY c POOR Correspondence to: Dr Maurice Enriquez-Sarano, Mayo Clinic, 2 First Street SW, Rochester, MN 5595, USA; sarano.maurice@mayo.edu Copyright 22 Mayo Foundation

More information

MITRAL VALVE PATHOLOGY WITH TRICUSPID REGURGITATION (AND PHT)

MITRAL VALVE PATHOLOGY WITH TRICUSPID REGURGITATION (AND PHT) UNIVERSITY OF PADUA, SCHOOL OF MEDICINE Department of Cardiac,Thoracic and Vascular Sciences Padua, Italy MITRAL VALVE PATHOLOGY WITH TRICUSPID REGURGITATION (AND PHT) Luigi P. Badano**, MD, PhD, FESC,

More information

What is the Role of Surgical Repair in 2012

What is the Role of Surgical Repair in 2012 What is the Role of Surgical Repair in 2012 The Long-Term Results of Surgery Raphael Rosenhek Department of Cardiology Medical University of Vienna European Society of Cardiology 2012 Munich, August 27th

More information